Clinical significance of genomic alterations of the CDK4-pathway and sensitivity to the CDK4 inhibitor PD 0332991 in melanoma.
Grant A. McArthur
Consultant or Advisory Role - Pfizer (U)
Research Funding - Pfizer
Richard J. Young
No relevant relationships to disclose
Karen E Sheppard
Research Funding - Pfizer
Victoria Mar
No relevant relationships to disclose
Kelly Waldeck
No relevant relationships to disclose
Stephen B. Fox
Consultant or Advisory Role - Pfizer (U)
Research Funding - Pfizer
Fergal C Kelleher
No relevant relationships to disclose
Wendy Liu
No relevant relationships to disclose
Alexander Dobrovic
Research Funding - Pfizer
Richard Pearson
Research Funding - Pfizer
John Kelly
No relevant relationships to disclose
James G. Christensen
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Sophia Randolph
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer